International ID
Conference Coverage
Are higher rifampin doses for pulmonary TB more effective?
Higher rifampin doses than customarily used offer better control of TB with safety.
News from the FDA/CDC
TB in 2017: Good news and bad news
Incidence is lower than ever, but elimination is still a long way off.
From the Journals
H. pylori eradication cuts new gastric cancers by half
The incidence of new gastric cancers was approximately 50% lower for those who received treatment for Helicobacter pylori infection.
News
CDC: Beware Brazil yellow fever outbreak
Yellow fever is spreading into tourist areas in Brazil; nonvaccinated individuals should avoid travel there.
News
FDA approves tests to screen for tickborne parasite in blood supply
The two new tests will screen whole blood and plasma samples.
Conference Coverage
ALT-70 score outperformed thermal imaging for cellulitis diagnosis
SAN DIEGO - The score surpassed thermal imaging on both positive and negative predictive value for diagnosing lower-extremity cellulitis.
Conference Coverage
Increasing sepsis survivorship creates new challenges
SAN ANTONIO– A new study calls for examination of the consequences of long-term sepsis survivorship.
Conference Coverage
Is MS caused by one-two punch of pinworm and Epstein-Barr virus?
SAN DIEGO – New theory suggests a double hit of infections could prime people to develop the disease.
From the Journals
Newborn oral rotavirus vaccine held effective
Administration of vaccine at time of birth may hold safety advantages.
From the Journals
Mogamulizumab active in HTLV-1–associated myelopathy
The phase 1-2a study shows potential for mogamulizumab in the treatment of HAM-TSP.
From the Journals
Recurrent serious infection risk captured in real world RA study
Organ class of the index infection has a large effect on future infections.